Workflow
光学光电子
icon
Search documents
本周IPO审4过4,再融资审2过2。两家科创板企业已光速提交注册!
Sou Hu Cai Jing· 2025-09-27 15:51
Group 1 - This week, four companies successfully passed the IPO review, aiming to raise a total of 12.233 billion yuan [1] - Among the approved IPOs, the company "Mole Thread" achieved the fastest review time of 88 days since the beginning of 2024 [2] - The company "Bai'ao Saitu" also submitted its registration on the same day it passed the review [2] Group 2 - Two companies were approved for refinancing this week, with a total fundraising target of 824 million yuan [1] - "Pulan Software" and "Maolai Optics" are the two companies that received approval for refinancing [1][2] Group 3 - "Bai'ao Saitu" focuses on preclinical CRO and biotechnology services, utilizing its self-developed gene editing technology [3] - The company plans to invest 45.358 million yuan in early drug development services, which constitutes 38.28% of its total fundraising [5] - The company reported a net profit of 33.54 million yuan for the last year, marking a significant turnaround from previous losses [4] Group 4 - "Hengdongguang" specializes in the research, manufacturing, and sales of passive optical devices in the optical communication field [7] - The company aims to raise 493.6329 million yuan through its IPO, with a focus on expanding its product offerings [8] - The company reported a net profit of 142.79 million yuan for the first half of 2025, reflecting a strong growth trajectory [9] Group 5 - "Mole Thread" is engaged in the research, design, and sales of GPUs and related products, having launched four generations of GPU architecture [14] - The company plans to raise 800 million yuan, with a significant portion allocated to AI chip development [18] - The company reported a net loss of 27.094 million yuan for the first half of 2025, indicating ongoing challenges despite its innovative product offerings [17] Group 6 - "Nanwang Digital" provides comprehensive digital construction solutions for the power energy sector, focusing on digital transformation [21] - The company aims to raise between 300 million and 476 million yuan through its IPO [22] - The company reported a net profit of 15.47 million yuan for the first half of 2025, showing a positive trend in profitability [23]
宇瞳光学:本公司及子公司的实际担保余额为160372.01万元
Core Insights - Yutong Optical announced that as of the date of the announcement, the actual guarantee balance of the company and its subsidiaries is 1,603.72 million yuan, which accounts for 66.62% of the company's audited net assets for 2024 [1] Summary by Categories - **Company Guarantees** - The actual guarantee balance of Yutong Optical and its subsidiaries is 1,603.72 million yuan [1] - This guarantee balance represents 66.62% of the company's audited net assets for the year 2024 [1] - There are no other external guarantees or overdue external guarantees reported by the company and its subsidiaries [1]
茂莱光学:可转债发行申请获通过
Xin Lang Cai Jing· 2025-09-26 09:54
茂莱光学公告,上海证券交易所上市审核委员会于2025年9月26日召开2025年第39次审议会议,对公司 向不特定对象发行可转换公司债券的申请进行了审议。根据会议审议结果,公司本次向不特定对象发行 可转换公司债券的申请符合发行条件、上市条件和信息披露要求。公司本次向不特定对象发行可转换公 司债券事项尚需获得中国证券监督管理委员会作出同意注册的决定后方可实施。 ...
光学光电子板块9月26日跌2.41%,东田微领跌,主力资金净流出24.98亿元
证券之星消息,9月26日光学光电子板块较上一交易日下跌2.41%,东田微领跌。当日上证指数报收于 3828.11,下跌0.65%。深证成指报收于13209.0,下跌1.76%。光学光电子板块个股涨跌见下表: | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 300303 聚飞光电 | | 2.15 Z | 13.41% | -6869.30万 | -4.28% | -1.46 Z | -9.13% | | 600552 凯盛科技 | | 1.05 Z | 21.75% | -2707.51万 | -5.60% | -7814.80万 | -16.15% | | 002654 万润科技 | | 7387.38万 | 2.74% | -5873.16万 | -2.18% | -1514.22万 | -0.56% | | 000020 深华发A | | 4842.77万 | 17.66% | -2357.72万 | -8. ...
蓝特光学股价跌5.18%,长安基金旗下1只基金重仓,持有2.7万股浮亏损失4.72万元
Xin Lang Cai Jing· 2025-09-26 02:22
Group 1 - The core point of the news is that Lante Optics experienced a decline of 5.18% in its stock price, reaching 32.05 CNY per share, with a trading volume of 114 million CNY and a turnover rate of 0.86%, resulting in a total market capitalization of 12.922 billion CNY [1] - Lante Optics, established on September 4, 2003, and listed on September 21, 2020, is located in Jiaxing City, Zhejiang Province. The company specializes in the research, production, and sales of optical components [1] - The main revenue composition of Lante Optics includes optical prisms (59.54%), glass aspheric lenses (26.41%), glass wafers (8.20%), and other products (5.85%) [1] Group 2 - From the perspective of fund holdings, Lante Optics is a significant investment for Chang'an Fund, with its Chang'an Industry Growth Mixed A fund holding 27,000 shares, accounting for 3.27% of the fund's net value, making it the eighth-largest holding [2] - The Chang'an Industry Growth Mixed A fund, established on September 29, 2022, has a latest scale of 18.2919 million CNY and has achieved a year-to-date return of 48.29%, ranking 1321 out of 8171 in its category [2] - The fund manager, Zhang Yunkai, has been in position for 1 year and 135 days, with the fund's total asset scale at 306 million CNY. The best return during his tenure is 79.91%, while the worst is 33.21% [2]
35股获券商推荐 东材科技目标价涨幅超50%|券商评级观察
Group 1 - The core viewpoint of the article highlights the target price increases for several listed companies, with notable gains for Dongcai Technology, Seres, and Gree Electric, showing target price increases of 51.97%, 37.62%, and 36.96% respectively [1][3] - On September 25, a total of 12 target price adjustments were made by brokerages, with the highest target price set at 32.43 yuan for Dongcai Technology [1][3] - A total of 35 listed companies received brokerage recommendations on September 25, including Sanyuan Shares, Anhui Weaving High-tech, and Yixin Pharmacy [1][3] Group 2 - On the same date, two companies had their ratings upgraded, with Renfu Pharmaceutical's rating raised from "Hold" to "Buy" by Shouchuang Securities, and Sanhuan Group's rating upgraded from "Hold" to "Buy" by Huazheng Securities [4][6] - A total of 10 companies received initial coverage from brokerages, with Frontier Biotech receiving a "Buy" rating from Kaiyuan Securities and Jiete Biotech also receiving a "Buy" rating from Xinda Securities [4][7] - Other companies receiving initial coverage include Bowei Alloy with a rating of "Hold" and Leisai Intelligent with a "Buy" rating, indicating a diverse range of sectors being covered [4][7]
波长光电换手率40.96%,深股通净卖出2592.70万元
Core Viewpoint - The stock of Wavelength Optoelectronics experienced a decline of 2.15% with a high turnover rate of 40.96%, indicating significant trading activity and potential volatility in the market [2]. Trading Activity - The total trading volume for the day was 2.439 billion yuan, with a fluctuation range of 9.75% [2]. - The stock was listed on the "Dragon and Tiger List" due to its turnover rate exceeding 40.96%, with net selling from the Shenzhen Stock Connect amounting to 25.927 million yuan [2]. - The top five trading departments accounted for a total transaction of 531 million yuan, with a net selling of 320,300 yuan [2]. Fund Flow - The stock saw a net outflow of 27.536 million yuan from main funds, with large orders showing a net inflow of 11.683 million yuan and a net outflow of 39.218 million yuan from larger funds [2]. - Over the past five days, the main funds experienced a cumulative net outflow of 52.066 million yuan [2]. Margin Trading Data - As of September 24, the margin trading balance for the stock was 452 million yuan, with a financing balance of 452 million yuan and a securities lending balance of 25,500 yuan [3]. - In the last five days, the financing balance increased by 149 million yuan, representing a growth of 48.93%, while the securities lending balance rose by 790 yuan, with a growth rate of 44.92% [3]. Specific Trading Details - The top buying and selling departments included the Shenzhen Stock Connect, which was both the largest buyer and seller, with buying amounting to 133.617 million yuan and selling at 159.544 million yuan [3][4]. - Other notable trading departments included various branches of Dongfang Caifu Securities, which participated significantly in both buying and selling activities [3][4].
光学光电子板块9月25日跌1.04%,腾景科技领跌,主力资金净流出19.82亿元
Market Overview - The optical and optoelectronic sector experienced a decline of 1.04% on September 25, with Tengjing Technology leading the drop [1] - The Shanghai Composite Index closed at 3853.3, down 0.01%, while the Shenzhen Component Index closed at 13445.9, up 0.67% [1] Stock Performance - Notable gainers in the optical and optoelectronic sector included: - Shenhua A (code: 000020) with a closing price of 15.36, up 10.03% and a trading volume of 121,200 shares [1] - Huichuangda (code: 300909) closed at 36.00, up 4.53% with a trading volume of 101,400 shares [1] - Linjie Sensor (code: 300701) closed at 14.15, up 4.04% with a trading volume of 225,200 shares [1] - Conversely, major decliners included: - Tengjing Technology (code: 688195) closed at 129.20, down 6.08% with a trading volume of 103,200 shares [2] - Chenglai Optics (code: 688502) closed at 445.50, down 4.86% with a trading volume of 20,100 shares [2] Capital Flow - The optical and optoelectronic sector saw a net outflow of 1.982 billion yuan from institutional investors, while retail investors contributed a net inflow of 1.441 billion yuan [2] - The capital flow for specific stocks indicated: - Lianchuang Electronics (code: 002036) had a net inflow of 1.05 billion yuan from institutional investors [3] - Shenma A (code: 000050) saw a net inflow of 86.32 million yuan from institutional investors [3] - TCL Technology (code: 000100) had a net inflow of 48.17 million yuan from institutional investors [3]
福晶科技(002222):三大业务稳健发展 至期光子打造长期增长新动力
Xin Lang Cai Jing· 2025-09-25 08:32
深耕精密光学三十余年,产品矩阵持续丰富。 福晶科技于1990 年由中国科学院福建物质结构研究所出资成立,2008 年于深交所上市。福晶科技以"光 电行业发展的有力推动者"为公司使命,现已成为全球知名的LBO 晶体、BBO 晶体、Nd:YVO4 晶体、 超精密光学元件、衍射光学元件、高功率光隔离器、声光器件及电光器件的龙头厂商。 具备"晶体+光学元件+激光器件"一站式综合能力公司是业内少数能够提供"晶体+光学元件+激光器 件"一站式综合服务的供应商,产品广泛应用于激光、光通讯、半导体、AR/VR、生命科学、无人驾 驶、环境监测设备以及检测分析仪器等诸多工业领域。 1)晶体元器件:公司核心非线性光学晶体和激光晶体领域处于国际领先地位,是全球规模最大的 LBO、BBO 晶体及其元器件的生产企业。其中 LBO 晶体器件被国家工信部和中国工业经济联合会评 为"制造业单项冠军产品(2019 年-2021 年)"。 2)精密光学产品:主要聚焦于中高端激光光学、通讯光学和高端光学设备元件市场,实现了应用于高 速光网络动态调控模块的新型棱镜光栅的批量生产,产品综合性能达到国际先进水平,成为国内外头部 企业重要的供应商。 3)激 ...
永新光学(603297):25H1业绩符合预期,高端显微镜释放成长动能
Huaan Securities· 2025-09-25 07:19
Investment Rating - The investment rating for the company is "Accumulate" (maintained) [1] Core Views - The company reported a revenue of 440 million yuan for the first half of 2025, representing a year-on-year growth of 3.0%, and a net profit attributable to shareholders of 110 million yuan, up 8.8% year-on-year [4] - The gross profit margin for the company was 40.3%, an increase of 1.4 percentage points year-on-year [4] - The optical components business achieved a revenue of 270 million yuan in the first half of 2025, with a year-on-year growth of 4.4% [4] - The high-end microscope business generated a revenue of 170 million yuan in the first half of 2025, reflecting a year-on-year increase of 0.9% [4] Financial Performance Summary - For the second quarter of 2025, the company achieved approximately 220 million yuan in revenue, a year-on-year increase of 4.2% and a quarter-on-quarter increase of 0.7% [4] - The net profit for the second quarter was 50 million yuan, down 2.5% year-on-year and down 5.4% quarter-on-quarter [4] - The company expects revenues for 2025-2027 to be 1.11 billion, 1.42 billion, and 1.81 billion yuan respectively, with net profits of 290 million, 360 million, and 450 million yuan respectively [5] Market Position and Growth Drivers - The company is experiencing growth in its optical components business, particularly in the automotive laser radar sector, with nearly one million units shipped in the first half of 2025 [4] - The high-end microscope segment is benefiting from a strategic focus on high-end products, with sales of high-end microscopes accounting for over 40% of total microscope sales [4] - The company has signed agreements with several overseas agents at the UK MMC exhibition, enhancing its brand influence [4]